Buy Bristol-Myers Squibb, Merck, 10-Year Treasury ETF And This Payments Stock: CNBC's 'Final Trades'

Comments
Loading...

On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners chose Bristol-Myers Squibb Co. BMY as his final trade. Shares of Bristol-Myers Squibb have added almost 30% year to date.

Brian Belski of BMO Capital Markets said that PayPal Holdings Inc. PYPL is “over performing … levitating after earnings” and is going to move higher if the market turns.

Check out other stocks making moves in the premarket.

Liz Young of BNY Mellon Investment Management said that fear was driving the yield down for the iShares 7-10 Year Treasury Bond ETF IEF and prices up.

Joseph Terranova of Virtus Investment Partners named Merck & Co Inc. MRK as his final trade.

BMY Logo
BMYBristol-Myers Squibb Co
$59.55-%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum84.12
Growth35.13
Quality-
Value14.74
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In: